Plasma Cell precursor and Other Disorders
Evaluating the Efficacy and Safety of Limiting Dexamethasone in Newly Diagnosed AL Amyloidosis Compared to Conventional Dosing
John Hanna, MD (he/him/his)
Resident Physician
Cleveland Clinic
Cleveland, Ohio, United States